Top 100 Most Cited Publications on CTLA-4 Molecule in Cancer Research: A Bibliometric Analysis

Top 100 Most Cited Publications on CTLA-4 Molecule in Cancer Research: A Bibliometric Analysis

The aim of this research is to use bibliometric analysis to investigate the status and patterns of the 100 most frequently cited publications regarding the cytotoxic Tlymphocyte- associated protein (CTLA-4) research for cancer. The articles published on the topic were retrieved from the core collect...

Full description

Bibliographic Details
Main Authors:	Hossam El Idrissi, Ibtissam Balar
Format:	Article
Language:	English
Published:	Shiraz University of Medical Sciences 2023-01-01
Series:	Middle East Journal of Cancer
Subjects:	bibliometric analysis ctla-4 protein cytotoxic t-lymphocyte antigen 4 cancer immunotherapy
Online Access:	https://mejc.sums.ac.ir/article_48210_41d465f56af0c7483cd9826efd063678.pdf

Similar Items

Role of cytotoxic T-lymphocyte antigen 4 (CTLA-4) expression in the pathogenesis of Warthin’s tumor growth
by: Alvionika Nadyah Qotrunnada, et al.
Published: (2022-12-01)

Do common infections trigger disease-onset or -severity in CTLA-4 insufficiency?
by: Máté Krausz, et al.
Published: (2022-11-01)

Corrigendum: Do common infections trigger disease-onset or -severity in CTLA-4 insufficiency?
by: Máté Krausz, et al.
Published: (2023-06-01)

Molecular classification of high-grade, muscle-invasive urothelial carcinomas and the relationship with CTLA-4 and PD-L1 expression
by: Fabiana T. B. Pereira, et al.
Published: (2023-12-01)

Role of CTLA4 immunohistochemistry in the diagnosis of colon cancers
by: Vishnu Narayanan, et al.
Published: (2022-01-01)

Antitumor effect of plant-produced anti-CTLA-4 monoclonal antibody in a murine model of colon cancer
by: Christine Joy I. Bulaon, et al.
Published: (2023-08-01)

The effect of HLA genotype on disease onset and severity in CTLA-4 insufficiency
by: Sara Posadas-Cantera, et al.
Published: (2025-01-01)

Cytotoxic T lymphocyte antigen-4 (CTLA-4) A49G polymorphism and autoimmune blood diseases
by: Faruk Aktürk, et al.
Published: (2010-06-01)

Cytotoxic T lymphocyte antigen-4 (CTLA-4) A49G polymorphism and autoimmune blood diseases
by: Faruk Aktürk, et al.
Published: (2010-06-01)

Elaborating on anti CTLA-4 mechanisms of action using an agent-based modeling approach
by: Ivan Azarov, et al.
Published: (2022-10-01)

Immunosuppressive Effects and Potent Anti-tumor Efficacy of mTOR Inhibitor Everolimus in Breast Tumor-bearing Mice
by: Davoud Rostamzadeh, et al.
Published: (2022-06-01)

PD-1 and CTLA-4 exert additive control of effector regulatory T cells at homeostasis
by: Joseph A. Pereira, et al.
Published: (2023-03-01)

CTLA4 DNA methylation is associated with CTLA-4 expression and predicts response to immunotherapy in head and neck squamous cell carcinoma
by: Friederike Hoffmann, et al.
Published: (2023-07-01)

Identification of CTLA-4-Positive Cells in the Human Tonsil
by: Markus Tiemann, et al.
Published: (2021-04-01)

Antibody-Mediated Inhibition of CTLA4 Aggravates Atherosclerotic Plaque Inflammation and Progression in Hyperlipidemic Mice
by: Kikkie Poels, et al.
Published: (2020-08-01)

Comprehensive Evaluation of Anti-PD-1, Anti-PD-L1, Anti-CTLA-4 and Their Combined Immunotherapy in Clinical Trials: A Systematic Review and Meta-analysis
by: Ze Xiang, et al.
Published: (2022-05-01)

Bispecific antibodies targeting CTLA-4: game-changer troopers in cancer immunotherapy
by: Pooya Farhangnia, et al.
Published: (2023-06-01)

Editorial: Microbiota and metabolites in cancer immunotherapy
by: Giandomenico Roviello, et al.
Published: (2022-12-01)

Anti-CTLA-4 antibodies in cancer immunotherapy: selective depletion of intratumoral regulatory T cells or checkpoint blockade?
by: Fei Tang, et al.
Published: (2018-04-01)

Impact of CTLA-4 checkpoint antibodies on ligand binding and Transendocytosis
by: Cayman Williams, et al.
Published: (2022-08-01)

CTLA-4 gene mutation and multiple sclerosis: A case report and literature review
by: Ting-Wei Lin, et al.
Published: (2022-06-01)

Clinical Application of Immune Checkpoint Inhibitors CTLA-4 in Solid Tumors
by: LI Tao, et al.
Published: (2023-05-01)

CTLA-4 silencing in dendritic cells loaded with colorectal cancer cell lysate improves autologous T cell responses in vitro
by: Farid Ghorbaninezhad, et al.
Published: (2022-08-01)

Studying Cytotoxic T-lymphocyte- Associated Antigen-4 (CTLA-4) gene Polymorphism in a Sample of Iraqi Women with Polycystic Ovarian Syndrome
by: Haneen Subhee Shaheed, et al.
Published: (2019-12-01)

Successful Treatment of T Cell-Mediated Acute Rejection with Delayed CTLA4-Ig in Mice
by: James S. Young, et al.
Published: (2017-09-01)

Development of a Highly Sensitive Hybrid LC/MS Assay for the Quantitative Measurement of CTLA-4 in Human T Cells
by: Dong Wei, et al.
Published: (2023-04-01)

A study on the efficacy and Safety Evaluation of a novel PD-1/CTLA-4 bispecific antibody
by: Qi Song, et al.
Published: (2024-11-01)

CTLA-4 Blockade of Natural Killer Cells Increases Cytotoxicity against Acute Lymphoid Leukaemia Cells Neda
by: Neda Parvini, et al.
Published: (2024-02-01)

Long term impact of CTLA4 blockade immunotherapy on regulatory and effector immune responses in patients with melanoma
by: Janet Retseck, et al.
Published: (2018-07-01)

The top 100 most cited papers in insomnia: A bibliometric analysis
by: Qingyun Wan, et al.
Published: (2023-01-01)

Relationship Between the Expression of PD-1 and CTLA-4 on T Lymphocytes and the Severity and Prognosis of Sepsis
by: Wang L, et al.
Published: (2023-04-01)

The expression of CTLA-4 in hepatic alveolar echinococcosis patients and blocking CTLA-4 to reverse T cell exhaustion in Echinococcus multilocularis-infected mice
by: Yuxuan Yang, et al.
Published: (2024-03-01)

Tumour-draining lymph nodes in head and neck cancer are characterized by accumulation of CTLA-4 and PD-1 expressing Treg cells
by: Krzysztof Piersiala, et al.
Published: (2022-09-01)

Targeting immunosuppressive Ly6C+ classical monocytes reverses anti-PD-1/CTLA-4 immunotherapy resistance
by: B. Leticia Rodriguez, et al.
Published: (2023-06-01)

CTLA-4 blockade in the treatment of colorectal cancer with microsatellite instability
by: Diana Russo, et al.
Published: (2021-03-01)

The top 100 most cited articles in acne vulgaris: a bibliometric analysis
by: Sapir Itzhaki Gabay, et al.
Published: (2024-02-01)

Functional analysis of CTLA4 promoter variant and its possible implication in colorectal cancer immunotherapy
by: Mariana Angulo-Aguado, et al.
Published: (2023-08-01)

Phenotypic Characteristics of PD-1 and CTLA-4 Expression in Symptomatic Acute Hepatitis A
Published: (2016-03-01)

The top 100 most cited articles on mucopolysaccharidoses: a bibliometric analysis
by: Ruyu Liao, et al.
Published: (2024-04-01)

Application of lasers in dentistry: a bibliometric study of the top 100 most-cited papers
by: Marco Aurélio Benini PASCHOAL, et al.
Published: (2022-07-01)